A Phase I Study of YK012 in Primary Membranous Nephropathy

NCT07234474 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Excyte Biopharma Ltd